Keywords: losses, dip, canada, lorus, canadian, biopharmaceutical, firm

Losses dip at Canada's Lorus

Article | 24 January 2005

Print This

Canadian biopharmaceutical firm Lorus Therapeutics has reported a loss of C$5.9 million ($4.8 million), or C$0.03 per share, for the three ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in